PD-L1 positive
Clinical trials for PD-L1 positive explained in plain language.
Never miss a new study
Get alerted when new PD-L1 positive trials appear
Sign up with your email to follow new studies for PD-L1 positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer vaccine plus immunotherapy shows promise in Hard-to-Treat cancers
Disease control OngoingThis study combines the CIMAvax EGF vaccine with immunotherapy drugs (nivolumab or pembrolizumab) to treat advanced non-small cell lung cancer and squamous head and neck cancer. The vaccine aims to slow tumor growth, while the immunotherapy helps the immune system attack cancer c…
Matched conditions: PD-L1 POSITIVE
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Promising drug cocktail takes on tough breast cancer
Disease control OngoingThis phase 3 trial tests whether combining sacituzumab govitecan (Trodelvy) with pembrolizumab (Keytruda) works better than standard chemotherapy plus pembrolizumab for people with advanced triple-negative breast cancer that has a protein called PD-L1. About 443 participants who …
Matched conditions: PD-L1 POSITIVE
Phase 3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 26, 2026 17:48 UTC